Clinical Research Directory
Browse clinical research sites, groups, and studies.
Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences
Sponsor: London School of Economics and Political Science
Summary
This study of current or former cancer patients will evaluate the effect of learning about uncertainties with the benefits of a new cancer drug on their hypothetical decisions to take the drug and their perceptions of the drug's effectiveness.
Official title: Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3000
Start Date
2026-07-14
Completion Date
2026-10-01
Last Updated
2026-08-04
Healthy Volunteers
No
Conditions
Interventions
Control
No uncertainty information
Unvalidates surrogate endpoint
Zenova has only been shown to shrink the size of tumors. It is unknown whether Zenova improves how patients feel or how long they live.
Limited study population
Zenova has not been studied in patients similar to Alex (patients with her race and ethnicity). It is unknown whether Zenova will work and what harms it will have for patients like her.
Small magnitude of effect
It is unknown whether patients with non-small cell lung cancer will notice an improvement with Zenova.
Multiple uncertainties
All 3 statements shown above